Physician profile
Deena A Kleinerman
NPI 1356388946
$3,216.50
in general payments reported to CMS, 2019-2025
36 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $550 · 2020: $495 · 2021: $489 · 2022: $858 · 2023: $454 · 2024: $370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $824.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $823.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $440.29 | 2019-2023 | |
| Daiichi Sankyo INC. | $242.55 | 2019-2023 | Injectafer |
| Pfizer INC. | $186.82 | 2019-2022 | |
| Aspira Women'S Health INC | $182.30 | 2022-2024 | Ova1 |
| Therapeuticsmd, INC. | $152.16 | 2020-2022 | |
| Astellas Pharma US INC | $146.67 | 2020-2024 | Veozah, Myrbetriq |
| Myovant Sciences INC. | $141.44 | 2022 | |
| Millicent US INC | $136.01 | 2019-2024 | Femring, Intrarosa |
| Duchesnay USA Incorporated | $118.68 | 2019 | |
| Evofem Biosciences, INC. | $118.59 | 2021-2023 | Phexxi |
| Coopersurgical, INC. | $118.22 | 2019-2023 | Paragard T 380a |
| Exeltis, USA INC. | $106.94 | 2019-2024 | Slynd |
| Shield Therapeutics INC | $103.39 | 2024 | |
| Mayne Pharma Commercial LLC | $93.45 | 2021-2022 | |
| Allergan, INC. | $89.52 | 2019-2020 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Women'S Health, INC. | $82.05 | 2023 | Myrisk |
| Bayer Healthcare Pharmaceuticals INC. | $81.05 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $59.26 | 2023 | Myfembree |
| Dysis Medical, INC. | $58.76 | 2020 | |
| Organon LLC | $57.25 | 2022-2023 | Nexplanon |
| Sage Therapeutics, LLC | $56.75 | 2021-2022 | |
| Exact Sciences Corporation | $53.29 | 2024 | Cologuard Collection Kit |
| Amag Pharmaceuticals, INC. | $48.11 | 2019 | |
| Avion Pharmaceuticals | $43.80 | 2019-2022 | |
| Vertical Pharmaceuticals, LLC | $43.07 | 2019-2020 | |
| Hologic Sales and Service, LLC | $41.10 | 2019-2021 | |
| Agile Therapeutics, INC. | $34.86 | 2021 | |
| Merck Sharp & Dohme LLC | $34.51 | 2022-2024 | Gardasil, Gardasil 9 |
| Cumberland Pharmaceuticals, INC. | $30.61 | 2021 | |
| Becton, Dickinson and Company | $26.36 | 2024 | Bd Max System, Bd Max Instrument |
| Kerecis Limited | $17.90 | 2022 | |
| Medtronic, INC. | $16.73 | 2022 | |
| Mylan Pharmaceuticals INC. | $15.54 | 2022 | |
| Tactile Systems Technology INC | $13.79 | 2019 | |
| Zyla Life Sciences, INC. | $12.68 | 2020 | |
| Scynexis, INC. | $12.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deena Kleinerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.